Search

Jyotsna V. Dabbi

Examiner (ID: 13828, Phone: (571)270-3270 , Office: P/2872 )

Most Active Art Unit
2872
Art Unit(s)
2872
Total Applications
614
Issued Applications
349
Pending Applications
74
Abandoned Applications
213

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3648721 [patent_doc_number] => 05639744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Bile acids derivatives useful in the therapy of the biliary calculosis from cholesterol and of the pathologies caused by cholestasis' [patent_app_type] => 1 [patent_app_number] => 8/416155 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8128 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639744.pdf [firstpage_image] =>[orig_patent_app_number] => 416155 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/416155
Bile acids derivatives useful in the therapy of the biliary calculosis from cholesterol and of the pathologies caused by cholestasis Apr 3, 1995 Issued
08/413729 1-SUBSTITUTED VITAMIN D3 ANALOGUES Mar 30, 1995 Abandoned
Array ( [id] => 3828107 [patent_doc_number] => 05760025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses' [patent_app_type] => 1 [patent_app_number] => 8/414909 [patent_app_country] => US [patent_app_date] => 1995-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37689 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 672 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760025.pdf [firstpage_image] =>[orig_patent_app_number] => 414909 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/414909
Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses Mar 30, 1995 Issued
Array ( [id] => 3695730 [patent_doc_number] => 05661141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => '19-oxygenated steroids as therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 8/409832 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10867 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661141.pdf [firstpage_image] =>[orig_patent_app_number] => 409832 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/409832
19-oxygenated steroids as therapeutic agents Mar 26, 1995 Issued
Array ( [id] => 3564317 [patent_doc_number] => 05525745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Intermediates in the preparation of 19-nor vitamin D compounds' [patent_app_type] => 1 [patent_app_number] => 8/410858 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5119 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525745.pdf [firstpage_image] =>[orig_patent_app_number] => 410858 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/410858
Intermediates in the preparation of 19-nor vitamin D compounds Mar 26, 1995 Issued
Array ( [id] => 3493510 [patent_doc_number] => 05561125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-01 [patent_title] => 'Estradiol derivative and growth inhibiting composition thereof' [patent_app_type] => 1 [patent_app_number] => 8/408381 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6340 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/561/05561125.pdf [firstpage_image] =>[orig_patent_app_number] => 408381 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/408381
Estradiol derivative and growth inhibiting composition thereof Mar 21, 1995 Issued
08/408392 NOVEL ESTRADIOL DERIVATIVE-ALKYLATING AGENT CONJUGATE WITH REDUCED HORMONAL ACTIVITY, PROCESS FOR PREPARING THE SAME COMPOUNDS USEFUL FOR THE PREPARATION THEREOF, AND GROWTH INHIBITING COMPOSITION CONTAINING THE CONJUGATE OR ESTRADIOL DERIVATIVE Mar 21, 1995 Abandoned
Array ( [id] => 3540172 [patent_doc_number] => 05480878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Method for treating prostatic hypertrophy with estradiol derivatives' [patent_app_type] => 1 [patent_app_number] => 8/408389 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6348 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480878.pdf [firstpage_image] =>[orig_patent_app_number] => 408389 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/408389
Method for treating prostatic hypertrophy with estradiol derivatives Mar 21, 1995 Issued
Array ( [id] => 3580468 [patent_doc_number] => 05491138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-13 [patent_title] => 'Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative' [patent_app_type] => 1 [patent_app_number] => 8/407962 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6351 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/491/05491138.pdf [firstpage_image] =>[orig_patent_app_number] => 407962 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/407962
Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative Mar 21, 1995 Issued
Array ( [id] => 3492617 [patent_doc_number] => 05536713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-16 [patent_title] => '19-Nor-vitamin D.sub.3 compounds with substitutent at 2-position' [patent_app_type] => 1 [patent_app_number] => 8/406646 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8605 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/536/05536713.pdf [firstpage_image] =>[orig_patent_app_number] => 406646 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/406646
19-Nor-vitamin D.sub.3 compounds with substitutent at 2-position Mar 19, 1995 Issued
Array ( [id] => 3625334 [patent_doc_number] => 05602248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Process for preparation of 9.alpha.-chloro-11.beta.-formyloxypregna-3,20-diones' [patent_app_type] => 1 [patent_app_number] => 8/405110 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3506 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 407 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602248.pdf [firstpage_image] =>[orig_patent_app_number] => 405110 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/405110
Process for preparation of 9.alpha.-chloro-11.beta.-formyloxypregna-3,20-diones Mar 15, 1995 Issued
Array ( [id] => 3686674 [patent_doc_number] => 05663157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => '22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents' [patent_app_type] => 1 [patent_app_number] => 8/362438 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7338 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663157.pdf [firstpage_image] =>[orig_patent_app_number] => 362438 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/362438
22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents Mar 15, 1995 Issued
08/405472 PROCESS FOR PREPARATION OF 9ALPHA-CHLORO-11BETA-FORMYLOXYPREGNA-3, 20-DIONES Mar 15, 1995 Abandoned
Array ( [id] => 3698313 [patent_doc_number] => 05596110 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Process for the preparation of 3 .beta., 14 .beta.-dihydroxyethianaldehyde' [patent_app_type] => 1 [patent_app_number] => 8/405354 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1205 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/596/05596110.pdf [firstpage_image] =>[orig_patent_app_number] => 405354 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/405354
Process for the preparation of 3 .beta., 14 .beta.-dihydroxyethianaldehyde Mar 15, 1995 Issued
Array ( [id] => 3555944 [patent_doc_number] => 05519153 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Medrogestone production' [patent_app_type] => 1 [patent_app_number] => 8/403312 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3652 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/519/05519153.pdf [firstpage_image] =>[orig_patent_app_number] => 403312 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/403312
Medrogestone production Mar 13, 1995 Issued
Array ( [id] => 3577013 [patent_doc_number] => 05523427 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-04 [patent_title] => 'Medrogestone production' [patent_app_type] => 1 [patent_app_number] => 8/403314 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3653 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/523/05523427.pdf [firstpage_image] =>[orig_patent_app_number] => 403314 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/403314
Medrogestone production Mar 13, 1995 Issued
08/394850 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1 ALPHA-HYDROXYLATED DERIVATIVES Feb 26, 1995 Abandoned
Array ( [id] => 3499058 [patent_doc_number] => 05532391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Homologated vitamin D.sub.2 compounds and the corresponding 1.alpha.-hydroxylated derivatives' [patent_app_type] => 1 [patent_app_number] => 8/394579 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10365 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532391.pdf [firstpage_image] =>[orig_patent_app_number] => 394579 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/394579
Homologated vitamin D.sub.2 compounds and the corresponding 1.alpha.-hydroxylated derivatives Feb 26, 1995 Issued
Array ( [id] => 3601180 [patent_doc_number] => 05559257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Process for the preparation of tetrachloro-1,4-benzoquinone' [patent_app_type] => 1 [patent_app_number] => 8/392469 [patent_app_country] => US [patent_app_date] => 1995-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5245 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559257.pdf [firstpage_image] =>[orig_patent_app_number] => 392469 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/392469
Process for the preparation of tetrachloro-1,4-benzoquinone Feb 21, 1995 Issued
Array ( [id] => 3547097 [patent_doc_number] => 05554774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-10 [patent_title] => 'Preparation of chlorinated violanthrones or isoviolanthrones' [patent_app_type] => 1 [patent_app_number] => 8/386665 [patent_app_country] => US [patent_app_date] => 1995-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1294 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/554/05554774.pdf [firstpage_image] =>[orig_patent_app_number] => 386665 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/386665
Preparation of chlorinated violanthrones or isoviolanthrones Feb 9, 1995 Issued
Menu